Ep190: Neil Kumar on Building a Rare Disease Drug Company
The Long Run with Luke Timmerman
00:00
Commercial launch and global partnerships
Neil describes self-commercialization in the U.S., partnership with Bayer in Europe, and responsibilities to patients.
Play episode from 57:50
Transcript
